Estrogen biology: New insights into GPER function and clinical opportunities

详细信息    查看全文

• 作者：Eric R. Prossnitz^a ; ^{eprossnitz@salud.unm.edu" class="auth_mail} ; Matthias Barton^b ; ^{barton@access.uzh.ch" class="auth_mail}
• 关键词：eNOS ; endothelial nitric oxide synthase ; ERK1/2 ; extracellular signal-related kinases-1/2 ; ER伪 ; estrogen receptor alpha ; ER尾 ; estrogen receptor beta ; GPER ; G protein-coupled estrogen receptor 1 ; GPR30 ; G protein-coupled receptor 30 ; MAPK ; mitogen-activated protein kinase ; mER ; membrane-associated estrogen receptor (伪 or 尾) ; NO ; nitric oxide ; PI3K ; phosphatidylinositol-3-kinase
• 刊名：Molecular and Cellular Endocrinology
• 出版年：25 May 2014
• 年：2014
• 卷：389
• 期：1-2
• 页码：71-83
• 全文大小：1475 K

文摘

Estrogens play an important role in the regulation of normal physiology, aging and many disease states. Although the nuclear estrogen receptors have classically been described to function as ligand-activated transcription factors mediating genomic effects in hormonally regulated tissues, more recent studies reveal that estrogens also mediate rapid signaling events traditionally associated with G protein-coupled receptors. The G protein-coupled estrogen receptor GPER (formerly GPR30) has now become recognized as a major mediator of estrogen’s rapid cellular effects throughout the body. With the discovery of selective synthetic ligands for GPER, both agonists and antagonists, as well as the use of GPER knockout mice, significant advances have been made in our understanding of GPER function at the cellular, tissue and organismal levels. In many instances, the protective/beneficial effects of estrogen are mimicked by selective GPER agonism and are absent or reduced in GPER knockout mice, suggesting an essential or at least parallel role for GPER in the actions of estrogen. In this review, we will discuss recent advances and our current understanding of the role of GPER and the activity of clinically used drugs, such as SERMs and SERDs, in physiology and disease. We will also highlight novel opportunities for clinical development towards GPER-targeted therapeutics, for molecular imaging, as well as for theranostic approaches and personalized medicine.